Requests similar to 'Data re Blood clots etc reports from Covid18 vaccines'
Details of second dose incidents of VITT following AZ vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Z. Dare on .
Awaiting classification
Dear Z Dare,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Divis...
Weekly hospitalisations from Adverse Reactions to the Coronavirus vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Karl Rainer on .
Information not held
Dear Mr Rainer,
Please find the attached in response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medici...
Adverse Effects of Covid "Vaccination"
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .
Partially successful
Dear Ms Jones,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division
Med...
Isolation document of Covid 19 and Ingredients of Pfizer vaccine
Response by Medicines and Healthcare Products Regulatory Agency to ANNA Frances on .
Partially successful
FOI 20/576
Dear Anna Frances,
Thank you for your email.
The list of ingredients in the Pfizer/BioNTech vaccine is available in the
Informa...
Covid-19 Vaccination - Adverse Side effects- Blood Clots and Astra Zeneca
Response by Medicines and Healthcare Products Regulatory Agency to Mairead Price on .
Awaiting classification
Dear Ms Price,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Div...
Age range and sex distribution of post AZ vaccine CVST cases and fatalities
Response by Medicines and Healthcare Products Regulatory Agency to O. Sullivan on .
Awaiting classification
Dear Sir/ Madam,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
Demographic data of patients suffering from CVST and Thrombocytopenia following COVID-19 AZ Vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Maria Imaz on .
Awaiting classification
Dear Ms Imaz,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division
Med...
Astrazeneca clot demographics
Response by Medicines and Healthcare Products Regulatory Agency to Vicky Thomson on .
Successful
Dear Ms. Thomson,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Divis...
AstraZeneca trial data
Response by Medicines and Healthcare Products Regulatory Agency to vikki spit on .
Awaiting classification
FOI 22/715
Dear Vikki Spit
Thank you for your email.
Regarding Q1, the clinical data for the AZ vaccine is available through the European Medicines...
Age range and sex distribution of patients with thrombo-embolic events with concurrent thrombocytopenia cases post second dose AZ vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Joanna Rodgers on .
Awaiting classification
Dear Ms Rodgers,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines D...
Covid19 Vaccination Programme - Risk-Benefit Evidence
Response by Medicines and Healthcare Products Regulatory Agency to Bob Parkinson on .
Long overdue
FOI 21/374
Dear Mr Parkinson
Thank you for your email.
The authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca
vaccines was do...
June Raine emails
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .
Partially successful
FOI 22/745
Dear Ms Jones,
Thank you for your email.
Please find attached the response and documents to your FOI request.
Yours sincerely
MHRA Cust...
Childhood Vaccine Analysis Prints
Response by Medicines and Healthcare Products Regulatory Agency to Kristine Bondarenko on .
Awaiting classification
Dear Kristine Bondarenko,
I am writing in response to your request for information, received 23rd
October.
Please find the response to your reques...
Fatalities from Covid19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to ANNA Frances on .
Successful
Dear Ms Francis,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
How do you ensure that guidance provided to HCP's is acted on?
Response by Medicines and Healthcare Products Regulatory Agency to vikki spit on .
Awaiting classification
Dear Ms Spit,
Please find attached the response to your FOI internal review request.
Kind regards,
FOI Team
Safety & Surveillance Group
M...
Vaccine adverse reactions
Response by Medicines and Healthcare Products Regulatory Agency to Ian Dalton on .
Refused
Dear Mr Dalton,
Please find the attached in response to your Internal Review request.
Kind regards,
FOI Team
Vigilance and Risk Management of Med...
When are the ‘Covid-vaccine’ harms enough?
Response by Medicines and Healthcare Products Regulatory Agency to Bartholomeus Lakeman on .
Refused
FOI 21/785
Dear Bartholomeus Lakeman
Thank you for your email.
Please see below our response to the seven points that you raise:
...
Safety signal reporting for Pfizer/BioNTech Covid 19 Vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Mr B Kingsley on .
Partially successful
FOI 23/474
Dear Mr B Kingsley
Thank you for your email.
Please find attached the response and documentation to your FOI request.
Kind Regards
MHR...
Our Ref: FOI 22/605
Dear Mr/Ms Jackson,
Please see the attached response to your enquiry.
Kind Regards,
MHRA...
Freedom of Information request about Yellow Card reports for meningitis ACWY and diphtheria, tetanus and polio vaccinations (FOI-21-168)
Response by Medicines and Healthcare Products Regulatory Agency to Sue wright on .
Awaiting classification
Dear Sue Wright,
I am writing in response to your request for information, received 26th
November.
Please find the response to your request attach...
A package Insert of Fluenz Tetra nasal spray flu vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Kristine Bondarenko on .
Partially successful
Dear Ms Bondarenko,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Safety & Surveillance Group
Medicines and Healthca...
Information regarding Viral Spike Protein of SARS-CoV-2
Response by Medicines and Healthcare Products Regulatory Agency to Nicholas Wells on .
Information not held
Our Reference: CSC 57055
Dear Mr Wells
Thank you for your email.
Unfortunately we are unable to provide any more information than tha...
Adverse reactions to AstraZeneca COVID-19 Vaccine broken down by age range and first vs second dose
Response by Medicines and Healthcare Products Regulatory Agency to Richard Taylor on .
Partially successful
Dear Mr Taylor,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Di...
Astra Zeneca adverse reactions: batch PV46674
Response by Medicines and Healthcare Products Regulatory Agency to E McLaren on .
Successful
FOI 24/163
Dear E McLaren,
Thank you for your email.
Please find attached a response to your FOI request.
Kind regards,
F...
A package Insert of Boostrix-IPV diphtheria, tetanus, pertussis and polio vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Kristine Bondarenko on .
Successful
Dear Ms Bondarenko,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Safety & Surveillance Group
Medicines and Healthca...